Valuation: Gencurix Inc.

Market Cap 30.03B 21.6M 18.53M 17.3M 15.87M 29.85M 2.06B 30.34M 204M 79.94M 1.04B 81.1M 79.34M 3.42B P/E 2022
-1.86x
P/E 2023 -3.82x
Enterprise Value 35.66B 25.65M 22M 20.55M 18.85M 35.45M 2.45B 36.03M 242M 94.94M 1.23B 96.32M 94.22M 4.07B EV / Sales 2022
26.8x
EV / Sales 2023 34.6x
Free-Float
55.38%
Yield 2022 *
-
Yield 2023 -
1 day-4.68%
1 week-3.99%
Current month+13.79%
1 month+12.46%
3 months-33.60%
6 months-10.02%
Current year+11.73%
1 week 1,730
Extreme 1730
1,950
1 month 1,321
Extreme 1321
1,950
Current year 1,321
Extreme 1321
7,320
1 year 1,321
Extreme 1321
7,320
3 years 1,131
Extreme 1131
8,910
5 years 1,131
Extreme 1131
23,500
10 years 1,131
Extreme 1131
32,300
Manager TitleAgeSince
Chief Executive Officer 53 -
Chief Tech/Sci/R&D Officer 64 2014-12-31
Corporate Officer/Principal 61 2023-03-30
Director TitleAgeSince
Director/Board Member 43 2023-09-12
Director/Board Member 53 -
Director/Board Member 46 -
Change 5-day change 1-year change 3-year change Capi.($)
-4.68%-3.99%+8.65%-60.16% 29.2M
+2.01%-1.07%+178.88%+341.34% 21.92B
+1.03%+1.16%-42.44%-20.61% 10.03B
+11.79%+7.69%+363.76%+36.14% 8.1B
+0.22%-0.25%+82.19%+51.60% 6.56B
+8.54%+2.25%-38.37% - 6.43B
+0.39%+11.77%-9.34%-0.61% 6.26B
-5.29%-1.87%+69.84%+103.41% 4.38B
+0.60%-1.23%-14.71%-17.29% 4.24B
-1.05%+5.20%-17.58%-28.44% 2.89B
Average +1.36%+1.43%+58.09%+45.04% 7.08B
Weighted average by Cap. +2.61%+1.45%+96.97%+127.28%

Financials

2022 2023
Net sales 2.56B 1.84M 1.58M 1.47M 1.35M 2.54M 176M 2.59M 17.4M 6.81M 88.25M 6.91M 6.76M 292M 2.6B 1.87M 1.6M 1.5M 1.37M 2.58M 179M 2.63M 17.68M 6.92M 89.66M 7.02M 6.87M 296M
Net income -24.6B -17.69M -15.18M -14.17M -13M -24.45M -1.69B -24.85M -167M -65.48M -848M -66.43M -64.98M -2.8B -19.26B -13.85M -11.88M -11.1M -10.18M -19.14M -1.32B -19.46M -131M -51.27M -664M -52.02M -50.88M -2.2B
Net Debt 22.55B 16.22M 13.91M 12.99M 11.92M 22.41M 1.55B 22.78M 153M 60.03M 778M 60.9M 59.57M 2.57B 5.63B 4.05M 3.48M 3.25M 2.98M 5.6M 387M 5.69M 38.3M 15M 194M 15.21M 14.88M 642M
Logo Gencurix Inc.
Gencurix Inc. is a Korea-based company mainly engaged in the sale of medical equipments. In addition, the Company is involved in the manufacturing and sale of breast cancer test (BCT) kits, Korean genetic polymorphism diagnostic kits, lung cancer and colorectal cancer diagnostic kits. The BCT kits are used for analyzing the expression level of the cancer-related gene. The products are sold under the name of GenesWell.
Employees
-
Date Price Change Volume
26-08-19 ₩1,733.00 -4.68% 38,387
26-08-18 ₩1,818.00 +0.28% 92,887
26-08-14 ₩1,813.00 -1.47% 60,242
26-08-13 ₩1,840.00 +1.94% 149,028
26-08-12 ₩1,805.00 -3.32% 88,832
  1. Stock Market
  2. Stocks
  3. A229000 Stock